Panacos Pharmaceuticals, Inc. · Watertown, MA United States ·(NASDAQ (GM): PANC)

Panacos Pharmaceuticals isn't looking for a panacea, just new treatments for HIV. The company is focused on the development of small molecule drugs that treat serious infectious diseases, specifically the virus that causes AIDS. The company's pipeline includes several compounds in pre-clinical testing, including an HIV fusion inhibitor -- which may prevent HIV from replicating in the body. Like many smaller biotech firms, Panacos Pharmaceuticals has sold off some assets, shrunk its workforce to four employees, and is pursing strategic alternatives, including fresh capital sources to continue its operations, or selling the company. To read the full description, subscribe now.